Compare Mutual Funds
WhiteOak Capital Pharma and Healthcare Fund
Select a Mutual Fund
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.85
-
NAV
₹17.21
-
Fund Started
16 Jan 2024
-
Fund Size
₹792.84 Cr
-
Exit Load
-
-
1 Year
15.51%
-
3 Year
-
-
5 Year
-
-
Equity
92.61%
-
Cash
-0.28%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.10% |
JB Chemicals & Pharmaceuticals Ltd. | 6.49% |
Laurus Labs Ltd. | 4.31% |
Apollo Hospitals Enterprise Ltd. | 4.30% |
Max Healthcare Institute Ltd. | 4.02% |
Fortis Healthcare Ltd. | 3.39% |
Krishna Institute of Medical Sciences Ltd | 3.09% |
Cipla Ltd. | 3.04% |
Sai Life Sciences Ltd. | 3.01% |
Aurobindo Pharma Ltd. | 2.52% |
-
Name
-
-
Start Date
-
-
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
-
Launch Date
16 Jan 2024
-
